Ken Fisher Astrazeneca PLC Transaction History
Fisher Asset Management, LLC
- $227 Billion
- Q1 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Astrazeneca PLC stock. As of the latest transaction made, Fisher Asset Management, LLC holds 20,165,459 shares of AZN stock, worth $1.47 Billion. This represents 0.65% of its overall portfolio holdings.
Number of Shares
20,165,459
Previous 10,959,852
83.99%
Holding current value
$1.47 Billion
Previous $718 Million
106.4%
% of portfolio
0.65%
Previous 0.29%
Shares
35 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.16 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.96 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.59 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.32 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.28 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $226B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...